XML 57 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Common Stock Options and Restricted Stock (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Weighted Average Assumptions Using the Black-Scholes Option Pricing Model

The fair value of each option granted is estimated on the date of grant using the Black‑Scholes option‑pricing model with the following weighted average assumptions:

 

 

 

Year ended December 31,

 

 

 

2021

 

 

2020

 

Employees and directors:

 

 

 

 

 

 

 

 

Estimated volatility%

 

 

84.26

%

 

 

80.28

%

Expected life in years

 

 

6.25

 

 

 

6.31

 

Risk free interest rate%

 

 

1.36

%

 

 

0.69

%

Dividend yield

 

 

 

 

 

 

Schedule of Share-based Compensation Expense The following table summarizes share-based compensation expense included within the Company’s consolidated statements of operations:

 

 

 

Year ended December 31,

 

(In thousands)

 

2021

 

 

2020

 

Research and development

 

$

694

 

 

$

1,745

 

Selling, general and administrative

 

 

2,282

 

 

 

6,020

 

Cost of sales

 

 

19

 

 

 

335

 

Total

 

$

2,995

 

 

$

8,100

 

Schedule of Stock Option Activity

A summary of share‑based compensation activity for the year ended December 31, 2021 is presented below:

 

 

 

Number

of Shares

(In thousands)

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Remaining

Contractual Term

 

 

Intrinsic

Value

(In thousands)

 

Balance at December 31, 2020

 

 

1,331

 

 

$

127.13

 

 

 

 

 

 

 

 

 

Granted

 

 

336

 

 

 

3.72

 

 

 

 

 

 

 

 

 

Forfeited and expired

 

 

(481

)

 

 

121.78

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2021

 

 

1,186

 

 

$

94.38

 

 

 

5.5

 

 

$

 

 

Vested and expected to vest at December 31, 2021

 

 

1,172

 

 

$

95.42

 

 

 

5.5

 

 

$

 

 

Vested and exercisable at December 31, 2021

 

 

872

 

 

$

125.89

 

 

 

4.0

 

 

 

 

Schedule of Stock Options Activity, By Exercise Price Range

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of exercise price

 

Outstanding

as of

December 31,

2021

(In thousands)

 

 

Weighted-

average

remaining

contractual life

(In years)

 

 

Weighted-

average

exercise price

 

 

Exercisable

as of

December 31,

2021

(In thousands)

 

 

Weighted-

average

exercise price

 

$3.16 - $3.74

 

 

276

 

 

 

9.8

 

 

$

3.70

 

 

 

1

 

 

$

3.18

 

$3.75 - $14.46

 

 

284

 

 

 

7.1

 

 

 

11.98

 

 

 

257

 

 

$

12.77

 

$15.30 - $164.85

 

 

265

 

 

 

3.6

 

 

 

124.60

 

 

 

253

 

 

$

126.67

 

$165.30 - $214.44

 

 

277

 

 

 

2.5

 

 

 

197.68

 

 

 

277

 

 

$

197.70

 

$215.28 - $246.42

 

 

84

 

 

 

2.1

 

 

 

234.91

 

 

 

84

 

 

$

234.91

 

 

 

 

1,186

 

 

 

5.5

 

 

$

94.38

 

 

 

872

 

 

$

125.89

 

 

Schedule of Restricted Stock Activity

 

Restricted Stock

 

Number of Shares

(In thousands)

 

Nonvested at December 31, 2020

 

 

31

 

Granted

 

 

261

 

Vested

 

 

(104

)

Forfeited

 

 

(72

)

Nonvested at December 31, 2021

 

 

116